STOCK TITAN

Beta Bionics Announces Participation at Upcoming Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Beta Bionics (Nasdaq: BBNX) announced management will present at two upcoming investor conferences in November and December 2025. Presentations are scheduled for Wolfe Research 7th Annual Healthcare Conference on November 18, 2025 at 2:00 PM ET and Piper Sandler 37th Annual Healthcare Conference on December 2, 2025 at 4:30 PM ET. Both sessions will be webcast live and archived for replay. Webcast links will be posted in the company’s Investors & Events section at https://investors.betabionics.com.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction 1 Alert

+0.38% News Effect

On the day this news was published, BBNX gained 0.38%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

IRVINE, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced that management will present at two upcoming investor conferences (all Eastern Time):

  • Wolfe Research 7th Annual Healthcare Conference on Tuesday, November 18, 2025 at 2:00pm
  • Piper Sandler 37th Annual Healthcare Conference on Tuesday, December 2, 2025 at 4:30pm

The presentations will be webcast live. The link to the webcasts will be available on the Company’s website in the “Investors—Events & Presentations” section at https://investors.betabionics.com, and will be archived there for future replay following the events.

About Beta Bionics

Beta Bionics, Inc. is a commercial-stage medical device company engaged in the design, development, and commercialization of innovative solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing advanced adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The iLet Bionic Pancreas is the first FDA-cleared insulin delivery device that autonomously determines every insulin dose and offers the potential to substantially improve overall outcomes across broad populations of PWD. To learn more, visit www.betabionics.com.

Investor Relations:
Blake Beber
Head of Investor Relations
ir@betabionics.com

Media and Public Relations:
Karen Hynes
Vice President of Marketing
media@betabionics.com

Source: Beta Bionics, Inc.


FAQ

When will Beta Bionics (BBNX) present at the Wolfe Research Healthcare Conference?

Beta Bionics will present on November 18, 2025 at 2:00 PM ET.

When will Beta Bionics (BBNX) present at the Piper Sandler Healthcare Conference?

Beta Bionics will present on December 2, 2025 at 4:30 PM ET.

Where can investors watch the Beta Bionics (BBNX) conference webcasts live?

Live webcasts will be available and archived on the company’s Investors & Events page at https://investors.betabionics.com.

Will Beta Bionics (BBNX) archive the conference presentations for replay?

Yes. The company will archive the webcasts on its investor website for future replay.

What topics will Beta Bionics (BBNX) management cover at the November–December 2025 conferences?

The announcement states management will present company developments; specific presentation topics or slides will be available during the webcasts or on the investor site.
Beta Bionics, Inc.

NASDAQ:BBNX

BBNX Rankings

BBNX Latest News

BBNX Latest SEC Filings

BBNX Stock Data

1.29B
39.16M
6.49%
104.92%
7.16%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
IRVINE